ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 73 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2019. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $241,000 | +123.1% | 72,500 | +140.1% | 0.02% | +183.3% |
| Q1 2019 | $108,000 | -6.9% | 30,200 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $116,000 | -48.9% | 30,200 | +25.6% | 0.01% | -33.3% |
| Q3 2018 | $227,000 | -53.6% | 24,050 | -64.1% | 0.01% | -52.6% |
| Q2 2018 | $489,000 | +34.7% | 66,965 | -7.6% | 0.02% | +58.3% |
| Q1 2018 | $363,000 | -13.4% | 72,500 | -12.7% | 0.01% | 0.0% |
| Q4 2017 | $419,000 | +437.2% | 83,000 | +264.0% | 0.01% | +140.0% |
| Q3 2016 | $78,000 | -25.7% | 22,800 | -24.5% | 0.01% | -37.5% |
| Q2 2016 | $105,000 | – | 30,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,705,128 | $10,300,000 | 4.44% |
| RTW INVESTMENTS, LP | 5,666,754 | $15,754,000 | 0.59% |
| COWEN AND COMPANY, LLC | 926,200 | $2,575,000 | 0.22% |
| Hudson Bay Capital Management LP | 850,000 | $2,363,000 | 0.05% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,774,915 | $4,934,000 | 0.03% |
| Point72 Asset Management, L.P. | 1,897,284 | $5,274,000 | 0.03% |
| 683 Capital Management, LLC | 77,368 | $215,000 | 0.02% |
| Secure Asset Management, LLC | 10,000 | $28,000 | 0.02% |
| Qube Research & Technologies Ltd | 166,138 | $462,000 | 0.01% |
| Verition Fund Management LLC | 174,455 | $485,000 | 0.01% |